Reduced-Dose Post-Transplantation Cyclophosphamide (PTCy) Facilitates Faster T-cell Recovery with Clinical Implications for Engraftment, Chronic GVHD, and Non-Relapse Mortality

Transplantation and Cellular Therapy 2026

View at publisher

Authors: Ms. Xianghong Li, Shanzay M. Khan, Alessandra de Paula Pohl, Natalia S. Nunes, Natasha Vinod, Christopher George Kanakry

DOI: 10.1016/j.jtct.2025.12.348

Cited by: 0

Fields of Study & Subjects

Hematopoietic Stem Cell Transplantation Renal Transplantation Outcomes and Treatments Immunodeficiency and Autoimmune Disorders